- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02433080
Diet and Physical Activity in Uterine Cancer Survivors (DEUS)
Randomised, Controlled, Pilot Clinical Trial to Assess the Feasibility of a Healthy Eating and Physical Activity Program in Endometrial Cancer Survivors
Endometrial cancer is the most common gynaecological cancer in developed countries with more than 75% of the patients surviving for at least five years. However, most endometrial cancer survivors are overweight and obese and do not meet the current nutrition and physical activity recommendations. This can lower their quality of life and increase their risk for chronic diseases. Behaviour change interventions can help them feel better about themselves and improve their quality of life. Applying them shortly after treatment seems ideal as cancer survivors feel motivated to make changes about their lifestyle at this time point.
This study is to see if the investigators can design a project to measure how well a psycho-educational healthy eating and physical activity programme tailored to the survivors' needs works. Sixty-four endometrial cancer survivors diagnosed during the previous three years, and are all clear will be put by chance into one of two groups. One will receive the program. The other will receive usual care until the end of the trial and, then, a discussion and a self-help guide about eating well and being active following cancer treatment. This will help us to see if the programme makes a difference compared with usual care. The results will inform a larger study to test if a lifestyle program can improve the quality of life of uterine cancer survivors compared with usual care. The investigators will change the programme materials in response to the investigators' findings, making them available to services. The results will inform practice and research.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Low physical activity, poor diet and obesity are risk factors for the development of endometrial cancer. A growing body of evidence suggests that they may be linked with quality of life after cancer treatment. However, only about 1% of endometrial cancer survivors seem to meet the current fruit and vegetable, physical activity, and non-smoking recommendations; while 57% meets only the non-smoking recommendations, and 22% meet none of the recommendations,
These behaviours exist despite cancer diagnosis being perceived as a "teachable moment". Capitalising the "teachable moment" of cancer, behaviour change interventions in high-risk populations might be more effective than those targeting the general population.
Theory-based behaviour change interventions suggest that improving diet and physical activity is safe, acceptable, and feasible and can help cancer survivors improve their quality of life. In contrast, there are only limited studies to support these data in the United Kingdom to allow generalisability of these results. However, the majority of these interventions were long-term and resource intensive which may render them inappropriate for wide dissemination. Therefore, feasible and effective interventions are needed to promote implementation of the nutrition and physical activity guidelines.
The intervention is based on the Shape-Up eight-week weight management programme. This programme is based on "Social Cognitive Theory" and "Control Theory". A version of this program has been favourably evaluated in terms of acceptability, physical, and psychological outcomes. We have tailored this programme (Shape-Up following cancer treatment) to help endometrial cancer survivors improve their diet, and activity pattern. The focus of the programme lies on self-control, self-efficacy, and relapse prevention in terms of healthy eating and physical activity. Behavioural techniques will include self-monitoring of behaviour with the use of food and physical activity diaries, behavioural goal setting, action planning, graded tasks, problem solving, self-reward, and review of behavioural goals. It will also provide information about health consequences and emotional consequences, pros and cons, behavioural practice, habit formation, reducing exposure to cues for the behaviour, behaviour substitution, distraction, social support (unspecified), demonstration of behaviour (for resistance exercises), instructions on how to perform the behaviour (for resistance exercises), and reframing.
The DEUS pilot trial is an eight-week, two-arm, individually randomised, controlled pilot trial comparing the use of the "Shape-Up following cancer treatment" programme to usual care. According to Medical Research Council guidance for complex interventions, this is a Phase 2 feasibility study. Randomisation will be performed with minimisation using a 1:1 allocation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Greater London
-
London, Greater London, United Kingdom, E1 1BB
- Barts Health Nhs Trust
-
London, Greater London, United Kingdom, NW1 3AD
- University College London Hospital NHS Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women aged >18 years (no upper age limit)
- Women diagnosed with endometrial cancer (C54.1) within the previous 36 months
- Women who are able to understand spoken and written English
Exclusion Criteria:
- Women with stage IVB (metastatic) endometrial cancer (any metastasis beyond the pelvis)
- Women on active anti-cancer, and/or palliative treatment,
- Women having second primary cancer
- Women who lack mental capacity to decide to take part in the study and to participate in it (upon clinical team's judgement in accordance with the Mental Capacity Act 2005 Code of Practice 2007)
- Women with severe depression (upon consultant's judgement based on the Diagnostic and Statistical Manual of Mental Disorders-IV criteria)
- Women unavailable for longitudinal follow-up assessments
- Women who participated in a professionally delivered weight loss or exercise program during the previous 6 months
- Women with a World Health Organization performance score 3-4
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Shape-Up following cancer treatment
In addition to usual care, cancer survivors in the intervention group will participate in a behaviour change programme, called "Shape-Up following cancer treatment: a self-help programme on eating well and being active".
Participants will be allocated to groups of eight to ten.
These groups will meet every week for eight weeks and each session will last approximately 90 minutes.
The programme focuses on strategies for improving diet and physical activity in a self-help and peer education format.
Each week, one participant will volunteer to present a new concept (e.g.
regular eating, being active, eating a balanced diet, keep an eye on portion sizes, and manage internal and external triggers, and understanding food labeling) to the rest of the group.
|
The programme is based on "Social Cognitive Theory" and "Control Theory".
The focus of the programme lies on self-control, self-efficacy, and relapse prevention.
Other Names:
|
No Intervention: Control intervention
Participants in the control group will be offered usual care until the 24-week follow-up. Quantifying usual care is challenging, but preliminary qualitative work suggested that most survivors do not received any unsolicited advice about healthy eating and physical activity from their health care professionals after treatment. During the course of their participation in the trial, participants will be contacted only for the assessments. After the completion of the 24-week follow-up, participants will receive the booklet "Healthy living after cancer"; a brief self-help manual produced by the World Cancer Research Fund. Providing only this information aims to match the currently offered usual care as accurately as possible but also meet ethical standards. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recruitment Rate (Percentage of Potentially Eligible Participants Who Were Enrolled to the Study)
Time Frame: 6 months
|
Achieving a 30% recruitment rate of the potentially eligible participants
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change From Baseline in Health-related Quality of Life Score
Time Frame: Baseline, 8weeks, 24weeks
|
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 & European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module 24 Global quality of life scale ranging from 0-100 with higher scores indicating better quality of life
|
Baseline, 8weeks, 24weeks
|
Change From Baseline in Dietary Quality (24-h Dietary Recall)
Time Frame: Baseline, 8weeks, 24weeks
|
One 24-h dietary recall for each timepoint.
This is the combined total Alternate healthy eating index-2010 score ranging from 0-110 with higher scores indicating higher dietary quality.
|
Baseline, 8weeks, 24weeks
|
Change From Baseline in Physical Activity (Physical Activity Recall)
Time Frame: Baseline, 8weeks, 24weeks
|
7-day physical activity recall
|
Baseline, 8weeks, 24weeks
|
Change From Baseline in Hand-grip Strength
Time Frame: Baseline, 8weeks, 24weeks
|
Baseline, 8weeks, 24weeks
|
|
Change From Baseline in Weight
Time Frame: Baseline, 8weeks, 24weeks
|
Baseline, 8weeks, 24weeks
|
|
Change From Baseline in Fat Mass Index
Time Frame: Baseline, 8weeks, 24weeks
|
Using MC980 multi-frequency segmental body composition analyser.
Fat mass index was calculated as kg of fat mass divided by squared height in meters.
|
Baseline, 8weeks, 24weeks
|
Intervention Evaluation Questionnaire
Time Frame: 8weeks, 24weeks
|
Change in the self-assessment of the gained skills (Shape-Up self-efficacy score).
This is a total score 0-5 with higher scores indicating higher self-efficacy.
|
8weeks, 24weeks
|
Health Care Services Use - Medication
Time Frame: 24weeks
|
Number of currently prescribed medications over the 24 weeks of the trial (Self-reported)
|
24weeks
|
Adherence Rate
Time Frame: 8 weeks
|
The percentage of engaged participants attending at least one of the last three sessions of the intervention.
Engaged participants are those who have attended at least two sessions of the intervention.
|
8 weeks
|
Retention Rate
Time Frame: Baseline to 24weeks
|
Rate of complete follow-up
|
Baseline to 24weeks
|
Health Care Services Use - Number of General Practitioner Visits
Time Frame: 24weeks
|
Number of visits to their general practitioner over the 24 weeks of the trial (Self-reported)
|
24weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Anne Lanceley, PhD, University College, London
Publications and helpful links
General Publications
- Chiuve SE, Fung TT, Rimm EB, Hu FB, McCullough ML, Wang M, Stampfer MJ, Willett WC. Alternative dietary indices both strongly predict risk of chronic disease. J Nutr. 2012 Jun;142(6):1009-18. doi: 10.3945/jn.111.157222. Epub 2012 Apr 18.
- Koutoukidis DA, Lopes S, Atkins L, Croker H, Knobf MT, Lanceley A, Beeken RJ. Use of intervention mapping to adapt a health behavior change intervention for endometrial cancer survivors: the shape-up following cancer treatment program. BMC Public Health. 2018 Mar 27;18(1):415. doi: 10.1186/s12889-018-5329-5.
- Koutoukidis DA, Beeken RJ, Manchanda R, Burnell M, Ziauddeen N, Michalopoulou M, Knobf MT, Lanceley A. Diet, physical activity, and health-related outcomes of endometrial cancer survivors in a behavioral lifestyle program: the Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomized controlled pilot trial. Int J Gynecol Cancer. 2019 Mar;29(3):531-540. doi: 10.1136/ijgc-2018-000039. Epub 2019 Feb 4.
- Koutoukidis DA, Beeken RJ, Manchanda R, Michalopoulou M, Burnell M, Knobf MT, Lanceley A. Recruitment, adherence, and retention of endometrial cancer survivors in a behavioural lifestyle programme: the Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomised pilot trial. BMJ Open. 2017 Oct 8;7(10):e018015. doi: 10.1136/bmjopen-2017-018015.
- Koutoukidis DA, Beeken RJ, Manchanda R, Burnell M, Knobf MT, Lanceley A. Diet and exercise in uterine cancer survivors (DEUS pilot) - piloting a healthy eating and physical activity program: study protocol for a randomized controlled trial. Trials. 2016 Mar 10;17(1):130. doi: 10.1186/s13063-016-1260-1. Erratum In: Trials. 2017 Jan 18;18(1):28.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14/0765
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endometrial Neoplasms
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnAtypical Endometrial Hyperplasia | Recurrent Endometrial Carcinoma | Endometrial Adenocarcinoma | Stage IA Endometrial Carcinoma | Stage IB Endometrial Carcinoma | Stage II Endometrial Carcinoma | Stage IIIA Endometrial Carcinoma | Stage IIIB Endometrial Carcinoma | Stage IIIC Endometrial Carcinoma | Stage... and other conditions
-
Case Comprehensive Cancer CenterTerminatedStage IV Endometrial Carcinoma | Stage III Endometrial Carcinoma | Stage II Endometrial Carcinoma | Stage I Endometrial CarcinomaUnited States
-
Sohag UniversityNot yet recruitingEndometrial Cancer and Endometrial HyperplasiaEgypt
-
CHU de ReimsUnknownEndometrial Hyperplasia and Endometrial CancersFrance
-
Assistance Publique - Hôpitaux de ParisUniversité Montpellier; Ecole d'econmie de Paris (PSE)-Hospinnomics; Université...CompletedEndometrial Cancer Stage I | Endometrial Cancer Stage IIFrance
-
National Cancer Institute (NCI)CompletedRecurrent Endometrial Carcinoma | Endometrial Adenocarcinoma | Endometrial Clear Cell Carcinoma | Endometrial Papillary Serous Carcinoma | Stage IIIA Endometrial Carcinoma | Stage IIIB Endometrial Carcinoma | Stage IIIC Endometrial Carcinoma | Stage IVA Endometrial Carcinoma | Stage IVB Endometrial... and other conditionsCanada
-
Washington University School of MedicineMerck Sharp & Dohme LLCCompletedEndometrial Cancer | Endometrial Carcinoma | Neoplasms, EndometrialUnited States
-
Radboud University Medical CenterMaastricht University Medical Center; Erasmus Medical Center; Catharina Ziekenhuis... and other collaboratorsRecruitingEndometrial Cancer Recurrent | Endometrial Cancer Stage III | Endometrial Cancer Stage IVNetherlands
-
Peking University People's HospitalPeking University; Beihang UniversityRecruitingAtypical Endometrial Hyperplasia | Endometrial Carcinoma Stage IChina
-
West China Second University HospitalRecruitingAtypical Endometrial Hyperplasia | Endometrial CancerChina
Clinical Trials on Shape-Up following cancer treatment
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesityUnited States
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesityUnited States
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesityUnited States
-
The Miriam HospitalCompleted
-
The Miriam HospitalCompleted
-
University Medical Center GroningenCompleted
-
Norwegian University of Science and TechnologyHelse Midt-NorgeActive, not recruitingNeoplasm Metastasis | Neoplasms, ColorectalNorway
-
Shannon E. Sauer-ZavalaCompletedDepressive Disorder | Obsessive-Compulsive Disorder | Anxiety Disorders | Post Traumatic Stress DisorderUnited States
-
Shannon E. Sauer-ZavalaNational Institute of Mental Health (NIMH)Active, not recruitingObsessive-Compulsive Disorder | Anxiety Disorders | Post Traumatic Stress DisorderUnited States
-
Yi YangWuzhou Red Cross Hospital; General Hospital of Shenyang Military Region; Chinese... and other collaboratorsRecruiting